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INTRODUCTION
 Dietary fats and oils are well known to affect serum 
cholesterol homeostasis and play an important 
role in the development of atherosclerosis1-3 heart 
disease and cancer which are the main causes of 
death.4,5 The risk of coronary heart disease (CHD) 
is progressively increased with higher values for 
serum total cholesterol.6 It has been suggested 
that coronary artery disease was due to the 
postprandial accumulation of triglyceride-rich 
lipoprotein remnants,7 and the association between 
metabolic abnormalities and cardiovascular 
disease has been studied largely during fasting 
conditions.8-10 However, the important contribution 
of postprandial state to cardiovascular disease is 
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ABSTRACT
Background and Objective: The important contribution of postprandial state to cardiovascular disease is 
increasingly	being	recognized.	Diet	rich	in	antioxidant	may	have	beneficial	effects	on	preventing	coronary	
heart disease. This study was therefore aimed to evaluate bioactive components, antioxidant activity and 
postprandial atheroprotective effects of Vaccinium myrtillus (VM).
Methodology: Male rabbits weighing 2.15±13 gr were randomly designed into 3 groups of 8, using the 
following regimens: basic diet, hypercholesterolemic diet and hypercholesterolemic diet+VM. The 
concentration of total cholesterol (TC), LDL cholesterol, HDL cholesterol, Alanin aminotransferase (ALT), 
aspartate	aminotransferase	(AST),	fibrinogen,	factor	VII,	nitrite	and	nitrate	were	determined	in	rabbits.	
Results: Vaccinium myrtillus	decreased	LDL-c,	TC	and	ApoB,	liver	enzymes	(ALT,	AST)	and	inflammatory	
factors, while endothelial markers (nitrate and nitrate) had subtle decrease in VM treated rabbits. 
Conclusions: The results of this study suggest that consumption of VM, rich in antioxidant may have 
beneficial	 effects	 on	 preventing	 coronary	 heart	 disease	 and	 atherosclerosis	 by	 decreasing	 remnant	
lipoprotein values in postprandial state.
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spend the majority of non-sleeping hours in the 
postprandial state. Importantly postprandial 
hyperlipidemia may in fact be a better predictor of 
cardiovascular events than fasting lipids.
 The adverse effect of postprandial triglycerides is 
thought to be mediated by pro-atherogenic lipolysis 
products of lipoproteins, such as remnant lipoproteins 
and fatty acids, and even a transient increase in these 
factors may worsen vascular function.12-14 The associa-
tion between non-fasting triglyceride (TG) concentra-
tions and risk of coronary death was assessed in 37546 
Norwegian male participants, aged 35-49 years, with-
out a history of cardiovascular disease (CVD) and dia-
betes.13,15 This analysis detected a statistically signifi-
cant association between non-fasting TG and coronary 
death during an average of 9 years of follow-up.16 In 
a large cohort study, non-fasting TG showed a 5-fold 
risk of death due to coronary heart disease in women 
with a non-fasting TG concentration of 3.5 mmol/l or 
more compared to those with a level of less than1.5 
mmol, even after adjustment for traditional coronary 
risk factors.13 A prospective study conducted in 14916 
men aged 40 to 84 years, non-fasting TG concentra-
tions significantly predicted future risk of myocardial 
infarction.17 Based on the time after the last meal for 
baseline blood draws, 26509 initially healthy women 
in Women’s Health Study18 were stratified into fast-
ing (8 and more hours since last meal) and non-fasting 
groups (meal within 8 hours prior to blood collection).
 After adjustment for standard cardiovascular risk 
factors including total and HDL cholesterol, diabe-
tes status, body mass index (BMI) and C-reactive 
protein (CRP), fasting TG levels were not associated 
with incident of cardiovascular events over an 11-
year follow-up period. On the other hand, non-fast-
ing triglycerides maintained a strong relationship 
with future cardiovascular events even in the fully 
adjusted analyses. Moreover, after stratification by 
time since the last meal, TG concentrations meas-
ured 2-4 hours after the last meal were the strong-
est predictor of CVD events. It has been shown that 
diet low in saturated fat and rich in antioxidant may 
have beneficial effects on preventing coronary heart 
disease.19 From many years ago, plants have been 
used for medical purposes. Nowadays, it is esti-
mated that approximately 80% of the world popu-
lations benefit from herbal medicine. Herbs and 
spices are generally considered safe and proved to 
be effective against certain aliments.20,21 
 Recent investigations both in humans and ani-
mals showed beneficial effects of herbs such as Soy 
protein, Grape seed oil, cornelian cherry and apple 
juice on serum lipid profile.21-25 Vaccinium myrtil-
lus L. contains a range of micronutrients which are 
essential for health. It contains a high level of vi-
tamin C (ascorbic acid), folic acid, resveratrol and 
piceatannol.26 It may have additional health benefits 
because it is also rich in phytochemicals such as an-
thocyanins and flavonols which have antioxidant 
activities.27 The anthocyanins of Vaccinium myrtil-
lus also exhibit a range of biologic effects, including 
antioxidant,28 anti-inflamatory29 and vasodilatory 
actions.30 High levels of phenolics-mainly anthocy-
anins31 are considered to be the pharmacologically 
active and health-promoting, due to their anti-oxi-
dative properties. Oxidative stress plays an impor-
tant role in the initiation and progression of many 
heart diseases. Due to antioxidant and free radical 
scavenging activities of Vaccinium myrtillus, we 
planned to study the postprandial atheroprotec-
tive effect of hydroalcoholic extract of Vaccinium 
myrtillus, by measuring lipid profiles, blood glu-
cose level and the factors effective on the function 
of blood vessels (nitrite and nitrate). Anthocyanin, 
flavonoid and phenolic contents and antioxidant 
activity of the extract was also evaluated.
METHODOLOGY
 Fresh Vaccinium myrtillus was purchased from 
the local market in June and authenticated by 
a botanist in Medical Plants Research Center of 
Shahrekord University of Medical Sciences. A 
voucher specimen was deposited in its herbarium 
(Number 264). Vaccinium myrtillus was air dried 
and milled into fine powder. Then, it was extracted 
in cold maceration with ethanol 80% for 48 hours. 
To standardize the powder of plant, some factors 
like anthocyanins and polyphenoles were measured 
as follows:
Measurement of anthocyanin content in Vaccinium 
myrtillus: Anthocyanin assay was performed us-
ing this method.32  with a slight modification. The 
Aloe vera powder extract (1g) was added to 100 ml 
ethanol 95% and 1.5 ml normal hydrochloric acid 
and kept in refrigerator at 2-4 centigrade degrees 
for 12 hours. Then, the mixture was filtered and the 
residue was repeatedly washed with acidic ethanol 
solvent, and finally the volume of the solution was 
brought to 250 ml. Then, its absorption was deter-
mined in a one-centimeter cell in the wavelength of 
535 nm and its anthocyanin content was measured 
by the following formula:
A/98.2×25000=The total anthocyanin level (mg per 
100 grams of sample).
A=Absorbance sample
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Flavonoid compounds determination of the extract: 
Aluminum chloride colorimetry and Rutin meth-
od was used to assay the total flavonoids.33 First, 
standard solutions (Rutin in methanol 60%) with 
concentration levels of 25, 50, 100, 250 and 500 ppm 
were prepared. Then 1 ml from these solutions was 
transferred into test tubes and mixed with 1 ml of 
chloride aluminum 2%. Then, 6 ml potassium ac-
etate 5% was added and the optical density level 
was read after 40 minutes at 415 nm wavelength. 
The concentration levels of the standard solutions 
were assayed in three intervals. In order to meas-
ure the overall level of flavonoids in the extracts, 
0.01-0.02 g of the extracts was dissolved in metha-
nol 60%, reaching 10 ml. Then, using chloride alu-
minum colorimetry the total level of flavonoids was 
measured. However, instead of using the standard 
solution, 1 ml of the extract was added. The total 
flavonoid level was calculated in mg per one gram 
extract, equivalent to Rutin.
Total phenolic compounds determination of the 
extract: Total phenolic compounds were assayed 
equivalent to Gallic acid using Folin-Ciocalteucol-
orimetry.34 The standard solutions were prepared 
with concentrations of 12.5, 25, 50, 62.5, 100 and 125 
ppm of gallic acid in methanol 60%. Then, 0.1 ml 
from each sample was transferred into a test tube 
and 0.5 ml Folin-Ciocalteu 10% was added as reac-
tive agent. The solutions were left for 8 minutes at 
room temperature and then 0.4 ml sodium carbon-
ate 7.5% was added. The tubes were maintained for 
30 minutes at the laboratory temperature and then 
assayed in three intervals by a spectrophotometer 
(Unicouv 2010) at 765 nm wavelength. To measure 
the overall phenol in the extracts, 0.01-0.02 g of the 
extracts was solved in 60% methanol, reaching 10 ml 
and then, using Folin-Ciocalteu method, the overall 
level of phenol was measured. However, instead of 
using the standard solution, 0.1 ml extract solution 
was added. Finally, the overall phenol level was ob-
tained from the read optical density in mg/g extract 
in Gallic acid equivalent.
Antioxidant activity determination of the extract: 
b-carotene model was employed to measure the 
antioxidant activity of the extract.35 0.5 ml chloro-
form, 5 ml b-carotene (0.2 mg), 20 ml linoleic acid 
(20 mg) and 0.2 ml Tween 40 were mixed in a suit-
able container and incubated at 50°C for 10 minutes 
in order to remove the solvent. The solution was 
diluted with distilled water and mixed with 4 ml 
of aliquots in the following manner. The control so-
lution was prepared including 0.2 ml ethanol and 
0.2 ml of the extract sample with 0.15 ml ethanol 
and 0.05 ml turmeric extract. The optical density 
of the control group was recorded at t=0 and t=90 
at 470 nm wavelength and similar to the standard 
group. The samples were incubated in a bain-marie 
at 50°C. The antioxidant activity was measured on 
the basis of the ability of the samples in preventing 
the washing of b-carotene. The antioxidant activity 
was calculated through Formula 1 below.
(1) AA = 100 [1-(Ao- At)/(Aoo – Aot)]
Where, 
Ao: the optical density at t = 0
At: optical density of the sample at t = 90
Aoo and Aot: as optical density values in the control 
samples at t=0 and t=90, respectively.
Animals: 24 male rabbits weighing 2.15±13 gr were 
obtained from the Razi Institute (Karaj, Iran). The 
rabbits were housed in clean polypropylene cages 
keeping 4 rabbits per cage and kept for two weeks 
under the controlled temperature (22±2c) with a 12 
hour light and 12 hour dark cycle. The animals were 
fed with basic diet for two weeks in the experimen-
tal environment before the experiment was con-
ducted. All experiments were conducted accord-
ing to ethical standards and protocols approved by 
the Ethical Committee of Shahrekord University of 
Medical Sciences, Iran.
 The animals were evenly divided into three groups 
of eight rabbits in each group and treated as follows:
Group 1: Normal control group (NC), in which rab-
bits were fed with basic diet.
Group 2: High cholesterol group, in which the ani-
mas received 1% hypercholestrolic diet.
Group 3: High cholesterol + Vaccinium myrtillus 
group, in which the animals received 1% hyper-
cholestrolemic diet plus 2% Vaccinium myrtillus.
At the beginning of the experiment (after 15 hours 
fasting) and after 3 hours of treatment the blood 
samples of each rabbit were collected and imme-
diately stored in 2 different test tubes (containing 
0.5cc citrate) and serum were separated by 20 min 
centrifugation at 3500 rpm.
 Blood glucose level was measured using Biosys-
tem kits and the amount of HDL Cholesterol, LDL 
-cholesterol, triglyceride, total cholesterol, alanin 
amino transferase (ALT) and aspartate amino trans-
ferase levels were determined using pars-azmoon 
commercial kits (Iran) on the Hitachi 902 Autoana-
lyzer (Japan). For fibrinogen measurement, blood 
was collected and stored in citrate tubes and the 
plasma was measured by coagulation method us-
ing Mahsayaran kit (Iran).
Statistical Analysis: All the statistical analyses 
were carried out by SPSS software. The data were 
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represented as mean±SD. One-way Analysis of 
Variance and Dunnett’s multiple comparison tests 
were used to assess the differences. P Value <0.05 
was considered as statistically significant.
RESULTS
 After analyzing each 100 g of Cornus mas L. pow-
der yielded 11 ± 0.4 g ethanolic extract. The calcu-
lated levels for flavonoid and phenolic compounds 
were 17.98 ± 1.9 mg/g Rutin equivalent and 215.56 ± 
2.88 mg/g Gallic acid equivalent, respectively. The 
amount of anthocyanins in Vaccinium myrtillus L. 
was 398 mg/100 g and its antioxidant activity was 
46%. In the high cholesterol treated group, glucose, 
triglyceride (TG), fibrinogen, ALT, AST, total cho-
lesterol (TC), LDL-C levels increased in comparison 
with control group (P<0.05). Adding Vaccinium 
myrtillus extract to high cholesterol treated rabbits 
decreased LDL-C, cholesterol and ApoB (P<0.05), 
but not glucose and triglyceride levels (Table-I).
 Fibrinogen decreased after Vaccinium myrtillus 
treatment but factor VII changes were not signifi-
cant between three groups of rabbits. Vaccinium 
myrtillus decreased liver enzymes (ALT &AST) 
and inflammatory factors. The endothelial markers 
(Nitrite and nitrate) had subtle decrease (P>0.05) in 
Vaccinium myrtillus treated groups.
DISCUSSION
 Coronary vascular disease is increasingly being 
recognized the important contribution of postpran-
dial state.36 Significant evidence indicates that oxi-
dative stress leads to cell and tissue injury.37-39 An-
tioxidants represent a first line of defense against 
free radicals and reactive oxygen species (ROS) that 
target lipids, proteins and nucleic acids.40 A very 
promising way to overcome this is to use vegeta-
bles and fruits with antioxidant properties.41 The 
presence of antioxidants in many herbs and species 
can have beneficial protecting effect on retarding 
the process of lipid peroxidation and atherogenesis. 
Recently herbal medicines have gained the inter-
est of many researches.42 The extract of Vaccinium 
myrtillus showed considerable antioxidant activity 
which is in accordance with the results of previous 
studies.43 Glucose, TG, fibrinogen, ALT, AST, TC, 
LDL-C levels increased in high cholesterol treated 
rabbits (Group2) in comparison with normal con-
trol rabbits (Group1) which showed the model was 
successful in inducing hyperlipidemia.
 In our study, there was no significant changes re-
garding serum glucose level in Vaccinium myrtillus 
treated group while in Roghani et al study, Vaccin-
ium myrtillus treatment of diabetic rats did have a 
significant hypoglycemic effect after 2 and 4 weeks 
of the experiment (P<0.001).43 This may suggest that 
Vaccinium myrtillus has a significant hypoglycemic 
effect in diabetic patients and can decrease high lev-
el of glucose but significant changes not observed 
regarding serum glucose level in our study. This 
may be because of  different model of study and the 
lower serum glucose level in rabbits in comparison 
with diabetic rats.44 Remnant lipoproteins, as well 
as the oxidized low density lipoprotein (Ox-LDL), 
is easily taken into the macrophage in the arterial 
wall, promoting foam cell formation of macrophag-
es and forming atherosclerotic lesion.45 In the past 
few decades, numerous clinical trials have estab-
lished the efficacy of lowering low-density lipopro-
tein cholesterol (LDL-C) for the prevention of coro-
nary heart disease.46 Postprandially, LDL-C and 
cholesterol levels significantly decreased in rabbits 
treated with Vaccunium myrthillus in comparison 
with high cholesterol treated rabbits which suggest 
that Vaccinium myrtillus may be useful to prevent 
coronary heart disease. Vaccinium myrtillus re-
duced TG levels of rats on hyperlipidaemic diet but 
the reduction was not significant while indicated 
that active constituent(s) of Vaccinium myrtillus L. 
leaves may be potentially useful for treatment of 
dyslipidaemia.47
Table-I: Mean (±SD) of biochemical factors after treatment 
with Vaccinium Myrthillus LDL-C (low density 
lipoprotein), TG (triglyceride), TC(totalcholesterol), 
ApoB(apolipoprotein B), Alanine aminotransferase 
(ALT), aminotransferase Aspartate (AST).
Biochemical Factors Groups
 Normal High Vaccinium
 Diet Cholesterol  Myrthillus
  diet
LDL-C(mg/dl) 24.13±1.26* 39.31±3.20 19.38±1.9*
fibrinogen 218.9±2.6* 251±4.6 213.9±5.1*
  (mg/dl)
TG(mg/dl) 50.50±1.43* 120.56±5.45 115.88±14.52
TC(mg/dl) 56.63±0.68 91±3.37 70.25±2.09*
ALT(u/l) 26.63±0.50* 40±1.34 29.13±0.64*
AST(u/l) 29.75±0.53* 43.22±2.63 35.63±1.43*
Glucose(mg/dl) 51.25±3.12* 132±3.57 143.75±5.87
Factor VII 295.7±2.5 298.1±5.7 296±5.5
  (%phy.activite)
ApoB(mg/dl) 27.88±0.88 30.78±1.02 27.13±0.44*
Nitrate(µMol/l) 305.6± 108.8 430± 36.7 170.8± 97.3
Nitrite(µMol/l) 250.4± 10 249.3±10.4 211.2 ±45.6
*p<0.05: significant differences between high cholesterol 
group and others.
 Several carbohydrates are able to regulate lipemia 
and triglyceridemia. In Kazumi et al study, feeding 
glucose in Wistar fatty rats produced a similar 
increase in the activity of NADPH-generating 
enzymes and triglyceride concentrations or hepatic 
fatty acid synthetase activity which suggests 
that glucose stimulates triglyceride production.47 
Vaccinium myrtillus treatment in our study did 
not significantly decrease glucose which can justify 
not significant reduction in triglyceride level. Liver 
enzymes (AST, ALT) were significantly decreased 
in Vaccinium myrtillus treated rabbits. This 
confirm the protective effect of aqueous extract 
of Vaccinium myrtillus against oxidative stress 
toxicity in isolated rat hepatocyte,48 suggesting that 
antioxidants components of Vaccinium myrtillus 
extract may prove potentially useful effects against 
the intracellular oxidative stress. In Naderi et al 
study, total extract of black pepper decreased AST 
release from hepatocytes which was attributed 
to antioxidant components of black pepper.49 
Vaccinium myrtillus is rich in such antioxidant that 
can justify the result of our study.
 The development of atherosclerosis is a dynamic 
process that results from excessive inflammatory 
and fibroproliferative responses.50 NO may 
normally prevent atherosclerosis by inhibiting 
smooth muscle cell proliferation, inhibiting 
platelet aggregation and adhesion, and inhibiting 
leukocyte activation and adhesion.51 In our study 
plasma levels of nitrites/nitrates (as endothelial 
markers) decreased after Vaccinium myrtillus 
treatment, but this was not significant. Multiple 
administrations of Vaccinium myrtillus may result 
in a significant decrease in serum nitrites/nitrates 
levels. Fibrinogen is an acute phase protein and its 
level increases in many acute diseases.52Because 
fibrinogen is one of the risk factors of cardiovascular 
disease,53 its level was measured in this study. 
Hypercholesterolemic rabbits had higher baseline 
level of fibrinogen compared to normal control 
group and administration of Vaccinium myrtillus 
prevented this increase. Result of 11-year follow up 
suggested that factor VII activity is an independent 
predictor of cardiovascular mortality of a Sicilian 
population.54
 In our study, factor VII change was not significant 
between 3 groups of rabbits. This may be because of 
short duration of the study because its production 
in liver takes relatively a time. It is recognized that 
atherosclerotic risk of postprandial hyperlipidemia 
is derived from an increase of remnant lipoproteins. 
Increase of remnant lipoprotein values in 
postprandial state is one of coronary risk factors.55-58 
This result suggests that reduction in lipoprotein 
values may have protective effect against 
postprandial hyperlipidemia atherosclerosis. 
Vaccinium myrtillus effectively reduced LDL and 
total cholesterol which suggest that consumption 
of Vaccinium myrtillus, rich in antioxidants, may 
have beneficial effects on preventing coronary heart 
disease and atherosclerosis. The present findings 
indicate that consumption of Vaccinium myrtillus 
is potentially useful for treatment of hyperlipidemia 
in rabbits. Furthermore, it makes further studies 
crucial to understand the dose response of this herb.
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